Could A More Precise CRISPR/Cas9 System Treat Huntington’s Disease? – Labiotech.eu (blog)
Business Wire (press release) |
Could A More Precise CRISPR/Cas9 System Treat Huntington’s Disease?
Labiotech.eu (blog) Polish researchers tested a new variant of CRISPR/Cas9 that increases the gene-editing system’s precision in targeting specific DNA sequences, such as the gene responsible for Huntington’s disease. CRISPR/Cas9 offers a means of editing genes by … Charpentier/Doudna Patent Covering CRISPR-Cas9 Gene Regulation ApplicationsBusiness Wire (press release) Newly discovered CRISPR mechanism may prevent dangerous errorsPhys.Org |
Business Wire (press release) |
Charpentier/Doudna Patent Covering CRISPR-Cas9 Gene Regulation Applications
Business Wire (press release) DUBLIN–(BUSINESS WIRE)–ERS Genomics announced today that the European Patent Office (EPO) has granted Dr. Emmanuelle Charpentier, ERS Genomics’ co-founder, together with the University of California and University of Vienna, its second EU patent with … |
Business Wire (press release) |
Charpentier/Doudna Patent Covering CRISPR-Cas9 Gene Regulation Applications
Business Wire (press release) DUBLIN–(BUSINESS WIRE)–ERS Genomics announced today that the European Patent Office (EPO) has granted Dr. Emmanuelle Charpentier, ERS Genomics’ co-founder, together with the University of California and University of Vienna, its second EU patent with … |
Financial Times |
‘Holy grail’ of gene therapy still a long way off for cystic fibrosis
Financial Times Until six years ago, there was nothing that could stop the relentless march of cystic fibrosis, a relatively rare disease that affects roughly 75,000 people worldwide, which causes the build-up of thick mucus in the lungs, pancreas, and other organs … |